Single-use Bioreactors Market Expands with Innovations in Cell Culture and Vaccine Production

"The Single-use Bioreactors Market is estimated to reach at a high CAGR during the forecast period (2024-2031)." As per DataM intelligence research report

Market growth opportunities(2025-2031):

The single‐use bioreactor market is set for rapid expansion, driven by the increasing demand for flexible and scalable manufacturing in biologics and cell/gene therapies. Single-use systems offer time‐efficiency in facility setup and enable swift batch turnover across multiproduct portfolios. Innovation in real-time sensors, modular designs, and perfusion platforms enhances control and throughput in both small-scale and commercial settings. Growing biologics production including vaccines and personalized medicines continues to fuel adoption in CMOs and biotech companies. Sustainability gains from reduced water and energy use support wider uptake among environmentally conscious users.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/single-use-bioreactors-market?sp

Single-use Bioreactors Market: Recent Industry Developments

✅ June 2025 - Sartorius
Launched BIOSTAT STR® Generation 4 single-use bioreactor system with enhanced automation and scalability.
Aimed at commercial-scale bioproduction for monoclonal antibodies and vaccines.

✅ May 2025 - Thermo Fisher Scientific
Announced $150M investment in its biologics manufacturing site in St. Louis, US.
Expansion includes upgraded single-use bioreactor suites for faster clinical delivery.

✅ April 2025 - Cytiva (Danaher)
Unveiled XcellerexTM XDR 50+ bioreactor with integrated real-time monitoring.
Designed to bridge the gap between process development and commercial scale.

✅ March 2025 - Eppendorf
Launched BioBLU® c plus 1000 bioreactor for large-scale microbial applications.
Supports flexibility in GMP manufacturing and seamless tech transfer.

✅ Feb 2025 - Merck KGaA (MilliporeSigma)
Invested €130M in new single-use production facility in Molsheim, France.
The site will increase supply of Mobius® bioreactors and related consumables.

Single-use Bioreactors Market: Market Drivers

The surge in biologics, including monoclonal antibodies and cell therapies, is a major catalyst driving adoption of disposable bioreactor platforms. Cost advantages such as no cleaning validation, reduced downtime, and lower capital requirements make single-use systems increasingly attractive. Expanding outsourcing in CDMOs and SMEs accelerates demand for modular, adaptable technology. Technological advances like improved sensors, automation, and low-shear mixing-enhance process consistency and regulatory compliance. Emergence of personalized and precision therapies requiring smaller batch sizes also favors single-use flexibility.

Strategic Players Driving the Single-use Bioreactors Market Forward:

ABEC, Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation, Celltainer, Distek, Inc., Merck KGaA, PBS Biotech, Inc., CYTIVA and Eppendorf SE.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/single-use-bioreactors-market?sp

Segment Covered in the Single-use Bioreactors Market:

➥By Product: Single-use Bioreactors System, Single-use Media Bag, Single-use Filtration Assemblies, Others
➥By Type: Bubble Column Single-use Bioreactors, Stirred Tank Single-use Bioreactors, Wave Induced Single-use Bioreactors
➥By Molecule Type: Monoclonal Antibodies (MABs), Vaccine, Stem Cells, Gene-Modified Cells, Other Molecules
➥By Cell Type: Mammalian Cells, Bacteria Cells, Yeast Cells, Other Cells
➥By Application: Research and Development, Process Development, Bio Production
➥By End User: Academic & Research Institutes, CROs and CMOs, Pharmaceutical & Biotechnology Companies, Others

Regional Analysis for Single-use Bioreactors Market:

North America leads the market due to its well-established biopharmaceutical infrastructure, stringent regulatory standards, and widespread adoption by CDMOs and pharma firms. Europe also holds a strong position, supported by innovation hubs and regulatory frameworks promoting disposable platforms. Asia‐Pacific is the fastest-growing region, driven by major investments in vaccine, biosimilar, and biotech manufacturing in countries like China, India, Japan, and South Korea-coupled with affordability and expansion of flexible facilities.

Why Purchase the Report for Single-use Bioreactors Market?:

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=single-use-bioreactors-market?sp

Conclusion:

The single‐use bioreactors market is poised for dynamic expansion as biologics and gene therapies become more prevalent and manufacturing demands become more flexible. North America and Europe continue to define industry benchmarks, while Asia‐Pacific is emerging as a strategic growth engine. Key success factors include investment in sensor-rich automation, process flexibility, and sustainable designs. Stakeholders should focus on modular platforms, strategic partnerships with CMOs, and scalability across regions to capitalize on this evolving biomanufacturing landscape.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.